OMI
Price
$6.60
Change
+$0.29 (+4.60%)
Updated
Aug 8, 12:34 PM (EDT)
Capitalization
2.11B
3 days until earnings call
SHTDY
Price
$11.92
Change
-$0.04 (-0.33%)
Updated
Aug 7 closing price
Capitalization
9.79B
Interact to see
Advertisement

OMI vs SHTDY

Header iconOMI vs SHTDY Comparison
Open Charts OMI vs SHTDYBanner chart's image
Owens & Minor
Price$6.60
Change+$0.29 (+4.60%)
Volume$200
Capitalization2.11B
Sinopharm Group
Price$11.92
Change-$0.04 (-0.33%)
Volume$86.86K
Capitalization9.79B
OMI vs SHTDY Comparison Chart in %
Loading...
OMI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OMI vs. SHTDY commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMI is a Hold and SHTDY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (OMI: $6.31 vs. SHTDY: $11.92)
Brand notoriety: OMI and SHTDY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: OMI: 73% vs. SHTDY: 324%
Market capitalization -- OMI: $2.11B vs. SHTDY: $9.79B
OMI [@Medical Distributors] is valued at $2.11B. SHTDY’s [@Medical Distributors] market capitalization is $9.79B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OMI’s FA Score shows that 1 FA rating(s) are green whileSHTDY’s FA Score has 2 green FA rating(s).

  • OMI’s FA Score: 1 green, 4 red.
  • SHTDY’s FA Score: 2 green, 3 red.
According to our system of comparison, SHTDY is a better buy in the long-term than OMI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OMI’s TA Score shows that 4 TA indicator(s) are bullish while SHTDY’s TA Score has 3 bullish TA indicator(s).

  • OMI’s TA Score: 4 bullish, 6 bearish.
  • SHTDY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both OMI and SHTDY are a bad buy in the short-term.

Price Growth

OMI (@Medical Distributors) experienced а -8.95% price change this week, while SHTDY (@Medical Distributors) price change was +0.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.67%. For the same industry, the average monthly price growth was +1.50%, and the average quarterly price growth was +1.84%.

Reported Earning Dates

OMI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Distributors (+1.67% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHTDY($9.79B) has a higher market cap than OMI($2.11B). OMI has higher P/E ratio than SHTDY: OMI (64.10) vs SHTDY (8.26). SHTDY YTD gains are higher at: -8.602 vs. OMI (-51.721). SHTDY has higher annual earnings (EBITDA): 26.2B vs. OMI (391M). SHTDY has higher revenues than OMI: SHTDY (552B) vs OMI (10.3B).
OMISHTDYOMI / SHTDY
Capitalization2.11B9.79B22%
EBITDA391M26.2B1%
Gain YTD-51.721-8.602601%
P/E Ratio64.108.26776%
Revenue10.3B552B2%
Total Cash243MN/A-
Total Debt2.32BN/A-
FUNDAMENTALS RATINGS
OMI vs SHTDY: Fundamental Ratings
OMI
SHTDY
OUTLOOK RATING
1..100
5010
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
9054
P/E GROWTH RATING
1..100
328
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDY's Valuation (22) in the null industry is somewhat better than the same rating for OMI (56) in the Medical Distributors industry. This means that SHTDY’s stock grew somewhat faster than OMI’s over the last 12 months.

SHTDY's Profit vs Risk Rating (79) in the null industry is in the same range as OMI (100) in the Medical Distributors industry. This means that SHTDY’s stock grew similarly to OMI’s over the last 12 months.

OMI's SMR Rating (97) in the Medical Distributors industry is in the same range as SHTDY (100) in the null industry. This means that OMI’s stock grew similarly to SHTDY’s over the last 12 months.

SHTDY's Price Growth Rating (54) in the null industry is somewhat better than the same rating for OMI (90) in the Medical Distributors industry. This means that SHTDY’s stock grew somewhat faster than OMI’s over the last 12 months.

OMI's P/E Growth Rating (3) in the Medical Distributors industry is in the same range as SHTDY (28) in the null industry. This means that OMI’s stock grew similarly to SHTDY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMISHTDY
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 17 days ago
73%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
53%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
OMI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGEYX27.30N/A
N/A
George Putnam Balanced Y
FFBFX27.95N/A
N/A
Emerald Finance & Bking Innovt Fd Inv
MSOCX27.65N/A
N/A
Morgan Stanley Inst International Opp C
DESGX24.26N/A
N/A
DWS ESG Core Equity Institutional
BTMGX18.30N/A
N/A
iShares MSCI EAFE Intl Idx G

SHTDY and

Correlation & Price change

A.I.dvisor tells us that SHTDY and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDY and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDY
1D Price
Change %
SHTDY100%
-0.32%
YI - SHTDY
21%
Poorly correlated
+0.95%
SHTDF - SHTDY
19%
Poorly correlated
N/A
HSIC - SHTDY
11%
Poorly correlated
-0.63%
ZYXI - SHTDY
9%
Poorly correlated
-5.16%
OMI - SHTDY
6%
Poorly correlated
-1.87%
More